Ledger.Open graph →

SEC Form D · Amendment · filed December 19, 2014

InCarda Therapeutics, Inc

Offering

$12.9M

Sold

$567K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Grace S. Colon · San Francisco, CAExec · Director Carlos A. Schuler · San Francisco, CAExec · Director Rangachari Narasimhan · San Francisco, CAExec · Director John S. Patton · San Francisco, CAExec · Director Scott G. Tuten · Bainbridge, GAExec · Director Andrew J. Scott · Addison, TXExec · Director Eric Singer · New York, NYExec · Director Brandon A. Tidwell · Salt Lake City, UTExec · Director Richard G. Bryan, Jr · Canonsburg, PAExec · Director Christopher Manice · New York, NYExec · Director David Peters · Wellesley, MAExec · Director Greg B. Calhoun · Bainbridge, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗